The FDA has eliminated a longstanding requirement that patients taking clozapine, an antipsychotic used for treatment-resistant schizophrenia, to submit blood test results before their prescriptions can be filled.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
